SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-031358
Filing Date
2024-08-12
Accepted
2024-08-12 17:16:22
Documents
64
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1330919
2 ex31-1.htm EX-31.1 17733
3 ex31-2.htm EX-31.2 18259
4 ex32-1.htm EX-32.1 7217
5 ex32-2.htm EX-32.2 7043
6 form10-q_002.jpg GRAPHIC 19865
  Complete submission text file 0001493152-24-031358.txt   6104686

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE immx-20240630.xsd EX-101.SCH 42213
8 XBRL CALCULATION FILE immx-20240630_cal.xml EX-101.CAL 56117
9 XBRL DEFINITION FILE immx-20240630_def.xml EX-101.DEF 189613
10 XBRL LABEL FILE immx-20240630_lab.xml EX-101.LAB 422402
11 XBRL PRESENTATION FILE immx-20240630_pre.xml EX-101.PRE 323826
66 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 807591
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Filer) CIK: 0001873835 (see all company filings)

IRS No.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41159 | Film No.: 241197934
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)